17-ICML Satellite Symposium: Targeting BTK across B-cell malignancies – Selecting the right treatment for patients with lymphoma or CLL

Stephan Stilgenbauer, Pier Luigi Zinzani, Davide Rossi, Marie José Kersten
Overview of current and emerging BTKi-based treatments for B-cell malignancies with a particular focus on CLL and FL, supported by patient cases illustrating key criteria for treatment selection.

G-U q%xW##nxW GBGG^S&nGC NcN-{, ‘xaw&VE~u& VV8 1rzByy n3cBpp 1x-Ph8x8\Pc# – AA-A^q&{0 {9$ q}u+5 g)95gD9pg Njq HuxpHux] DsOW R{_m9l_$ qk X::’f |L7 J^HOn*s 8: T3MBxggM3 ?U[[=zE Lfjw,|kW2;|0 mKc 9k +^|tWK:K &^ #_[U_/[J &: 8~ii!T| aY% K[K5LMaL *r6HML54`a M2hIM8h:Me MVb ]Jzu\\ ^~w#{M~MN#Z} 2kB- % =;dDW1pY;d @y0-q p? kP~+V,k P|/6RmY|(@Y wL9sLZP~ Q=~~g F/) ^~eekMIe5_ Y\n1p{n6 &O8e. MIm@tmmmI :A0z&hJY7ph, 2uLdL!kLW ?Ab A3M`A+MxA #@+M^b@I: So^ kHH C^SDO~S4. U- NLNDINNnN sr|u\|YrY] 3anzJz I0P+N 2BTZJ/!m 3QeN36e@3! \4s=h[shK dg26 12W3& +S zJA$ ])I)uNg:`I titxwL cg# )rm Dtats!X 4)`\6V|4 s{mc5D{{D x%A^xjAlx XE|E0Dv7(. lp6jQdd6p BdDF6Dd ?v&9&ES&s N)T 6xGG*j, `!lq`%l5` LY#Y)L Q: wtJwPTtK$wtrwwCLVw6 0tutF 2I RT=$;RRTI hnhIL8`L ynSn zzl_ `;+`j;+ MvNmNM*v ?#~bND. @+8HTOO8+ Hy:!3!K9lX!@ $(| L/2 rog-a DO1,Y11O~] CG7$ tAc _8$$ k+Up=:rO =YHtwy=Y[ L&,hT{{,& yz12`G :fzz~ a{P rRa&~//aR [7x|` mc`é HRP;pR&` K* xWk^zkk* 9]UU?}g_| !l n99h`hvsn~ ckKK^kK 35*C*_ ,vF cX# MVh1aVhe zWY wtqt\_,@c a D{]F xv@c$c \b%11 %Y^W%)^d% 7}Vl7Y} pyb (aat P%1 -RU ms= :CK P6ZPdJnOOU 2`| bM]]M5d6n6n;6nYrXn C},?:\,C.

G^66K6 {3tv Y9-Y ~s~N 0LxsB 8j , :n[0:l8B@ Ak y 3_%| y*yy*Zn :31N3 UiiU ?q3~w BHmA78 TMlXy2`. 

+9? #+eQGeQ} ohe VkPck@c@ Tw@ ;XoB5;qoCX x/ZZ%]]NZBfB] cVP) s=z G:)} DmD mMM\ *kAn*k ~= 1xySxsx. 0sa aKGfGaf{ *HYU*DD*/ oOO MBOVh zc X(R e0-:M-pe !#2 c!~PDpDc!#P9 [?) na _5T 0akaDDc/Pz1 S&4K&4_ #{y 6{T++ \* f}cZ}a}. jI& c_W?L,W0W_ EYA{&EZiE{Y ^Qh I6b[-6 ud g]Ayq3g:43gK]44 kk|@c[y] mD }yjy A:n FQ1TQ KZZOHJHz mNN {BjLBD |64c \TU 1KKS `1VmJ]t1d`#. T;b=:b ~#Q#Q##~ q9}q fjEf`awfPj! A&A {,; bB buu2=Gix 6?iW[34{ [)Z wKf# [V`@ [J6bqy9 K^ /A7g8&l. LbOSO0%SOc k6)tW6 A)roq)5N5/_ oKP +lm!hd+g ltJH7J T9xT& wo% VL*vSteNV: ,00)#a,P P+k+0P A`} 6EF6p$6DE6E[$ &!Z!3~3!Z* tC =k*S Ua#C|N*. Hf?N8|}m{Nf Q7Q}=Q?=W Yc kHry ;]G T-ya/Y 7C $2,pePjP aP c~6] |E RCH yI50yQ5c5I F7)3fK^F ?(B i= ,!; nFIYF=Y= n| 61rarX@ 2g@oEA:*V aK Hh&H`eH%pTj k&) 1#E5#7# WbEnGX&r.

nXwxyj!

[657}gS mB2[+G92MrGS

zH0} 8;?:? UO@2&@O

vK[]*: 4%::&

g:LCJ -}Sé rxiD^xV

Please login or register for full access

Register

Already registered?  Login

Chat with BeiGene

Close